AstraZeneca shares fall on report of potential China probe fallout
AstraZeneca shares recorded their biggest one-day drop since March 2020 on Tuesday following a report that dozens of senior executives at its China unit could be implicated in the largest insurance fraud case in the country's pharma sector in years.
(Yicai) Nov. 6 -- Major multinational automakers, including Volkswagen Group, Ford Motor, and Stellantis, reported disappointing sales in China in the quarter ended September as the country’s rapidly ...
AstraZeneca's (NASDAQ:AZN) selloff on Tuesday in response to reports that the company is facing a fraud investigation in ...
AstraZeneca’s stock price dropped by 8.4% during Tuesday’s trading in London after a report fueled fears of a potentially ...
AstraZeneca's shares have fallen more than 8% on speculation about an anti-corruption probe in China, its second-largest ...
Chinese authorities detained AstraZeneca employees amid a probe into data privacy breaches and unlicensed drug sales, stock ...
AstraZeneca said on Tuesday that it does not comment on speculative media reports, in response to a sharp drop in its share ...
The AstraZeneca share price has fallen almost 25% since late August. Is there value on offer for investors after this huge ...
Shares plunged 8.4pc, the most in four years, after the report by Chinese state-owned news organisation Yicai claimed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback